Latest California Healthline Stories
The saga of Martin Shkreli and Turing Pharmaceuticals focused a lot of attention on prescription drug prices, but no reversal of the exponential price increases for the lifesaving drug Daraprim resulted. The story offers an object lesson into the interworkings of the pharmaceutical market.
The scathing report cites a significant increase in cases of poor care — especially ones with the potential to cause serious injuries or death. A state lawmaker called the findings “very, very disturbing.”
Report cites frequent absences from work as evidence that untreated mental health problems can adversely affect the economic well-being of individuals and families — a dynamic that is most prevalent in communities of color.
The former secretary of the Department of Health and Human Services says the law eliminating penalties for most people who don’t have insurance coverage will hurt the insurance marketplaces.
Hospitals and private investors have pumped vast sums of money into an advanced type of radiology that mostly spares healthy tissue while attacking tumors. The spending hasn’t always paid off — leading some facilities to close or, as in the case of a San Diego center last year, file for bankruptcy.
President Donald Trump’s upcoming speech on drug prices comes after months of public comments and debate about tackling the issue.
Nationally, women outnumber men as specialists in obstetrics and gynecology — yet women remain underrepresented in leadership roles. Many OB-GYN patients say they prefer female doctors, as residency programs strive for diversity in race, ethnicity and even gender.
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Sarah Kliff of Vox.com, Anna Edney of Bloomberg News and Alice Ollstein of Talking Points Memo discuss the collapse of the nomination of White House physician Ronny Jackson to head the Department of Veterans Affairs. They also discuss new bipartisan congressional efforts to address the opioid epidemic. Plus, for extra credit, the panelists offer their favorite health policy stories of the week.
More than a dozen centers nationwide now ask terminal patients to allow speedy study of the diseases that kill them.
Self-management classes can help the tens of millions of Americans now diagnosed with Type 2 diabetes. But the education can come with a high price tag.